Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank 薬物名（臨床試験情報から抽出） KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins 2件: Admsc; HB-admscs---9件: 2, 4, 6, 13, 14, 46, 49, 51, 96 💬
2 Batoclimab 1件: Batoclimab1件: Batoclimab 💬 --2件: 11, 14 💬
3 Carmustine 2件: Carmustina; Carmustine1件: Carmustine 💬 --5件: 11, 13, 14, 28, 60 💬
4 Chlorpheniramine 0件: 2件: Chlorpheniramine maleate ,
Chlorphenamine 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 14 💬
5 Clostridium tetani toxoid antigen (formaldehyde inactivated) 1件: Tetanus toxoid2件: Tetanus toxoid adsorbed ,
Tetanus toxoid 💬 		--4件: 13, 14, 46, 50 💬
6 Cyclophosphamide 5件: Ciclofosfamida; Ciclofosfamide; Cyclophosphamid; Cyclophosphamide; Cyclophosphamide monohydrate2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--46件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 220, 221, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
7 Cytarabine 2件: Citarabina; Cytarabine2件: Cytarabine ,
Cytarabine hydrochloride 💬 		--7件: 11, 13, 14, 25, 34, 49, 60 💬
8 Dalfampridine 5件: 4-aminopyridine; 4-AP; Dalfampridine; Fampridina; Fampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬4件: 3, 4, 13, 14 💬
9 Dexamethasone 2件: Dexamethasone; Dexamethasone sodium phosphate3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬25件: 13, 14, 16, 19, 28, 35, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 296, 299, 331 💬
10 Eculizumab 1件: Eculizumab1件: Eculizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬8件: 11, 13, 14, 61, 62, 109, 221, 222 💬
11 Efgartigimod alfa 1件: Efgartigimod alfa1件: Efgartigimod alfa 💬 --7件: 11, 13, 14, 35, 53, 63, 162 💬
12 Empasiprubart 1件: Empasiprubart1件: Empasiprubart 💬 1件: C2 💬 6件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬2件: 14, 50 💬
13 Etoposide 1件: Etoposide2件: Etoposide ,
Etoposide phosphate 💬 		--12件: 11, 13, 14, 26, 28, 34, 54, 60, 65, 85, 164, 331 💬
14 Fibrinogen human 3件: Fibrinogen; Fibrinogen concentrate; Human fibrinogen1件: Fibrinogen I 125 💬 --5件: 14, 49, 65, 107, 288 💬
15 Fingolimod 2件: Fingolimod; Fingolimod hydrochloride3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 14, 156 💬
16 Human immunoglobulin G 6件: Human immunoglobulin G; Human normal immunoglobulin; Immune globulin; Immunoglobulin; Immunoglobulin G; Intravenous immunoglobulin1件: Globulin, immune 💬 --9件: 11, 13, 14, 43, 45, 50, 51, 63, 65 💬
17 Hyaluronidase (human recombinant) 2件: Hyaluronidase; Recombinant human hyaluronidase1件: Hyaluronidase 💬 --3件: 14, 28, 65 💬
18 Lipoic acid 1件: Lipoic acid1件: Thioctic acid 💬 --4件: 2, 13, 14, 20 💬
19 Melphalan 2件: Melphalan; Melphalan hydrochloride2件: Melphalan ,
Melphalan hydrochloride 💬 		--19件: 11, 13, 14, 19, 20, 28, 34, 46, 60, 62, 65, 96, 107, 164, 222, 234, 284, 285, 299 💬
20 Methylprednisolone 3件: Methylprednisolon; Methylprednisolone; Methylprednisolone acetate2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬48件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 127, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 💬
21 Nipocalimab 1件: Nipocalimab1件: Nipocalimab 💬 --6件: 11, 14, 46, 49, 53, 61 💬
22 Prednisolone 3件: Prednisolona; Prednisolone; Prednisolonum1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬41件: 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 60, 61, 63, 64, 66, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
23 Prednisone 2件: Prednisona; Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬54件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
24 Riliprubart 1件: Riliprubart1件: Riliprubart 💬 1件: C1S 💬 5件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 14 💬
25 Ripertamab 1件: Ripertamab---1件: 14 💬
26 Rituximab 1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬52件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
27 Rozanolixizumab 2件: Rozanolixizumab; UCB76651件: Rozanolixizumab 💬 --3件: 11, 14, 63 💬
28 Sodium chloride 2件: Natriumchlorid; Sodium chloride1件: Sodium chloride 💬 --23件: 2, 11, 13, 14, 34, 41, 46, 51, 53, 60, 67, 70, 96, 97, 193, 214, 215, 226, 227, 228, 288, 298, 299 💬